Altium Capital Management LP - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 63 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Altium Capital Management LP ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$3,071,000
+23.5%
625,469
+32.8%
0.81%
+39.7%
Q2 2021$2,487,000
+15.1%
470,949
+4.7%
0.58%
-3.8%
Q1 2021$2,160,000450,0000.60%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 808,431$3,501,0002.68%
AIGH Capital Management LLC 875,851$3,793,0001.54%
Healthcare Value Capital, LLC 100,000$433,0001.46%
SILVERARC CAPITAL MANAGEMENT, LLC 440,955$1,909,0001.11%
Opaleye Management Inc. 1,487,800$6,442,0000.84%
Worth Venture Partners, LLC 225,106$975,0000.77%
ARMISTICE CAPITAL, LLC 2,742,000$11,873,0000.40%
DELTEC ASSET MANAGEMENT LLC 245,399$1,063,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 278,011$1,204,0000.15%
Mosaic Family Wealth, LLC 91,807$398,0000.13%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders